McKesson Stock Price, News & Analysis (NYSE:MCK)

$162.60 5.40 (3.44 %)
(As of 12/17/2017 12:31 PM ET)
Previous Close$162.60
Today's Range$157.56 - $164.29
52-Week Range$133.82 - $169.29
Volume3.26 million shs
Average Volume2.05 million shs
Market Capitalization$33.90 billion
P/E Ratio13.37
Dividend Yield0.84%
Beta1.23

About McKesson (NYSE:MCK)

McKesson logoMcKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through two segments: McKesson Distribution Solutions and McKesson Technology Solutions. The distribution solutions segment distributes branded and generic pharmaceutical drugs and other healthcare-related products internationally and provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. Technology Solutions segment provides software and analytics, network solutions and technology-enabled services.

Receive MCK News and Ratings via Email

Sign-up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Retailers
Sub-IndustryHealth Care Distributors
SectorMedical
SymbolNYSE:MCK
CUSIP58155Q10
Phone415-983-8300

Debt

Debt-to-Equity Ratio0.66%
Current Ratio1.05%
Quick Ratio0.61%

Price-To-Earnings

Trailing P/E Ratio13.37
Forward P/E Ratio13.34
P/E Growth1.67

Sales & Book Value

Annual Sales$198.53 billion
Price / Sales0.17
Cash Flow$17.95 per share
Price / Cash9.06
Book Value$53.16 per share
Price / Book3.06

Profitability

Trailing EPS$21.09
Net Income$5.07 billion
Net Margins2.24%
Return on Equity24.87%
Return on Assets4.27%

Miscellaneous

Employees78,000
Outstanding Shares208,480,000

McKesson (NYSE:MCK) Frequently Asked Questions

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson announced a quarterly dividend on Thursday, October 26th. Stockholders of record on Friday, December 1st will be given a dividend of $0.34 per share on Tuesday, January 2nd. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.84%. The ex-dividend date of this dividend is Thursday, November 30th. View McKesson's Dividend History.

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) announced its earnings results on Thursday, October, 26th. The company reported $3.28 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $2.78 by $0.50. The business had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.69 billion. McKesson had a return on equity of 24.87% and a net margin of 2.24%. The business's revenue was up 4.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.94 earnings per share. View McKesson's Earnings History.

When will McKesson make its next earnings announcement?

McKesson is scheduled to release their next quarterly earnings announcement on Wednesday, January, 24th 2018. View Earnings Estimates for McKesson.

What guidance has McKesson issued on next quarter's earnings?

McKesson issued an update on its FY18 earnings guidance on Thursday, October, 26th. The company provided EPS guidance of $11.80-12.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $12.05.

Where is McKesson's stock going? Where will McKesson's stock price be in 2017?

15 analysts have issued 12-month price objectives for McKesson's shares. Their forecasts range from $130.00 to $193.00. On average, they anticipate McKesson's stock price to reach $173.33 in the next twelve months. View Analyst Ratings for McKesson.

What are Wall Street analysts saying about McKesson stock?

Here are some recent quotes from research analysts about McKesson stock:

  • 1. According to Zacks Investment Research, "Over the past three months, McKesson has been trading above the broader Medical/Dental – Supplies industry. Looking forward, management expects to gain with the gradually stabilizing generic and branded markets. The company recently posted stable numbers for the fourth-quarter fiscal 2017 (ended Mar 31, 2017) wherein earnings beat the Zacks Consensus Estimate, courtesy of a strong performance in the Distribution Solutions division. To boost growth the company has acquired CoverMyMeds for approximately $1.1 billion in the recent past. Also, cost-savings efforts remain encouraging. Furthermore, an inexpensive valuation and rising estimate revision trend for the current year indicates a pocket of opportunity for the stock. On the flip side, stiff competition, currency headwind and reimbursement issues remain challenges." (7/12/2017)
  • 2. Citigroup Inc. analysts commented, "MCK yesterday announced the completion of its previously-announced agreement w/Change Healthcare (CHC) to create a new HCIT company retaining the same name, combining substantially all of CHC's business and the majority of MCK Tech. Solutions, less its EIS segment which will remain in MTS. Initial plans to merge assets were announced on 6/28/16. Mgmt provided color on the NewCo's financial implications, largely consistent with expectations, with recognition occurring on a 1-month lag (reducing guided F4Q17 adj EPS by ~$0.15). We update our estimates to fully reflect today's guidance on the NewCo, but currently assume a full FY18 RAD contribution to MCK. Net, we maintain our Buy, as headwinds appear to be stabilizing while the WMT contract should improve purchasing power, with some offsets given initial Change dilution and a likely F2H18 loss of RAD; $175 TP (+$6), ~13-14x CY17 EPS, ~17% ETR." (3/6/2017)

Who are some of McKesson's key competitors?

Who are McKesson's key executives?

McKesson's management team includes the folowing people:

  • John Harvey Hammergren, Chairman of the Board, President, Chief Executive Officer (Age 58)
  • James A. Beer, Chief Financial Officer, Executive Vice President (Age 56)
  • Kathleen D. McElligott, Executive Vice President, Chief Technology Officer, Chief Information Officer (Age 61)
  • Lori Ann Schechter, Executive Vice President, Chief Compliance Officer, General Counsel (Age 55)
  • Jorge L. Figueredo, Executive Vice President - Human Resources (Age 56)
  • Paul Coleman Julian, Executive Vice President, Group President (Age 61)
  • Bansi Nagji, Executive Vice President - Corporate Strategy and Business Development (Age 52)
  • Edward A. Mueller, Lead Independent Director (Age 70)
  • Andrew D. Bryant, Independent Director (Age 67)
  • N. Anthony Coles Jr., M.D., Independent Director (Age 57)

Who owns McKesson stock?

McKesson's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Parnassus Investments CA (2.13%), Bank of New York Mellon Corp (1.22%), Pzena Investment Management LLC (1.18%), Caisse DE Depot ET Placement DU Quebec (0.86%), Wells Fargo & Company MN (0.84%) and Epoch Investment Partners Inc. (0.67%). Company insiders that own McKesson stock include Erin M Lampert, James A Beer, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, Nigel A Rees, Patrick Blake, Susan R Salka and Wayne A Budd. View Institutional Ownership Trends for McKesson.

Who sold McKesson stock? Who is selling McKesson stock?

McKesson's stock was sold by a variety of institutional investors in the last quarter, including Ameriprise Financial Inc., Point72 Asset Management L.P., Wells Fargo & Company MN, Canada Pension Plan Investment Board, Brandes Investment Partners LP, APG Asset Management N.V., Schwab Charles Investment Management Inc. and Skandinaviska Enskilda Banken AB publ. Company insiders that have sold McKesson company stock in the last year include Erin M Lampert, John H Hammergren, M Christine Jacobs and Marie L/Ca Knowles. View Insider Buying and Selling for McKesson.

Who bought McKesson stock? Who is buying McKesson stock?

McKesson's stock was acquired by a variety of institutional investors in the last quarter, including Baupost Group LLC MA, Pzena Investment Management LLC, Dimensional Fund Advisors LP, American Century Companies Inc., First Trust Advisors LP, Bank of New York Mellon Corp, Tavio Capital LLC and River & Mercantile Asset Management LLP. Company insiders that have bought McKesson stock in the last two years include Lori A Schechter and Susan R Salka. View Insider Buying and Selling for McKesson.

How do I buy McKesson stock?

Shares of McKesson can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is McKesson's stock price today?

One share of McKesson stock can currently be purchased for approximately $162.60.

How big of a company is McKesson?

McKesson has a market capitalization of $33.90 billion and generates $198.53 billion in revenue each year. The company earns $5.07 billion in net income (profit) each year or $21.09 on an earnings per share basis. McKesson employs 78,000 workers across the globe.

How can I contact McKesson?

McKesson's mailing address is ONE POST ST, SAN FRANCISCO CA, 94104. The company can be reached via phone at 415-983-8300 or via email at [email protected]


MarketBeat Community Rating for McKesson (MCK)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  669 (Vote Outperform)
Underperform Votes:  326 (Vote Underperform)
Total Votes:  995
MarketBeat's community ratings are surveys of what our community members think about McKesson and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

McKesson (NYSE:MCK) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.452.432.372.38
Ratings Breakdown: 1 Sell Rating(s)
9 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
10 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
10 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
11 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $175.28$174.89$173.94$175.32
Price Target Upside: 19.73% upside24.60% upside10.31% upside5.80% upside

McKesson (NYSE:MCK) Consensus Price Target History

Price Target History for McKesson (NYSE:MCK)

McKesson (NYSE:MCK) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/4/2017Deutsche BankInitiated CoverageBuy$175.00HighView Rating Details
11/9/2017Credit Suisse GroupReiterated RatingUnderperform$155.00 -> $130.00N/AView Rating Details
11/1/2017Needham & Company LLCReiterated RatingBuy -> Buy$178.00 -> $173.00N/AView Rating Details
10/27/2017Royal Bank of CanadaReiterated RatingHold$170.00N/AView Rating Details
10/24/2017MizuhoSet Price TargetHold$168.00N/AView Rating Details
10/18/2017Jefferies GroupSet Price TargetHold$165.00N/AView Rating Details
10/10/2017CowenUpgradeMarket Perform -> Outperform$176.00 -> $189.00N/AView Rating Details
9/19/2017Robert W. BairdUpgradeNeutral -> Outperform$175.00 -> $178.00LowView Rating Details
9/14/2017Morgan StanleyDowngradeOverweight -> Equal Weight$184.00 -> $172.00HighView Rating Details
6/29/2017Leerink SwannBoost Price TargetMarket Perform$170.00MediumView Rating Details
6/4/2017BarclaysSet Price TargetBuy$187.00LowView Rating Details
5/23/2017J P Morgan Chase & CoUpgradeNeutral -> Overweight$189.00MediumView Rating Details
4/17/2017Evercore ISIReiterated RatingOutperform$166.00LowView Rating Details
3/6/2017CitigroupBoost Price TargetBuy$169.00 -> $175.00N/AView Rating Details
1/18/2017Avondale PartnersUpgradeMarket Perform -> Outperform$157.00 -> $193.00N/AView Rating Details
11/11/2016Standpoint ResearchDowngradeBuy -> HoldN/AView Rating Details
9/19/2016ArgusReiterated RatingHoldN/AView Rating Details
9/16/2016Goldman Sachs GroupDowngradeBuy -> Neutral$210.00 -> $189.00N/AView Rating Details
6/30/2016Bank of AmericaReiterated RatingHoldN/AView Rating Details
6/29/2016FBR & CoReiterated RatingBuy$210.00N/AView Rating Details
6/1/2016Raymond James FinancialDowngradeStrong-Buy -> OutperformN/AView Rating Details
(Data available from 12/17/2015 forward)

Earnings

McKesson (NYSE:MCK) Earnings History and Estimates Chart

Earnings by Quarter for McKesson (NYSE:MCK)

McKesson (NYSE MCK) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/7/2018$3.14N/AView Earnings Details
10/26/2017Q2 2018$2.78$3.28$51.69 billion$52.06 billionViewN/AView Earnings Details
7/27/2017Q1 2018$2.81$2.46$51.22 billion$51.05 billionViewN/AView Earnings Details
5/18/2017Q4 17$3.04$3.39$49.48 billion$48.71 billionViewN/AView Earnings Details
1/25/2017Q317$2.95$3.03$50.71 billion$50.13 billionViewN/AView Earnings Details
10/27/2016Q217$3.05$2.94$24.16 billion$49.96 billionViewListenView Earnings Details
7/27/2016Q117$3.33$3.50$50.32 billion$49.73 billionViewListenView Earnings Details
5/4/2016Q416$3.14$2.44$46.83 billion$46.68 billionViewN/AView Earnings Details
1/27/2016Q316$3.13$3.18$48.97 billion$47.90 billionViewListenView Earnings Details
10/29/2015Q216$2.99$3.31$47.85 billion$48.60 billionViewListenView Earnings Details
7/29/2015Q116$2.89$3.14$46.02 billion$47.50 billionViewListenView Earnings Details
5/12/2015Q415$2.75$2.94$45.00 billion$44.93 billionViewListenView Earnings Details
2/5/2015Q315$2.61$2.89$44.81 billion$47.01 billionViewN/AView Earnings Details
10/28/2014Q215$2.73$2.79$42.99 billion$44.76 billionViewN/AView Earnings Details
7/31/2014Q115$2.34$2.49$40.65 billion$44.06 billionViewN/AView Earnings Details
5/12/2014Q414$2.40$2.55$35.89 billion$38.14 billionViewN/AView Earnings Details
1/31/2014Q314$1.85$1.45$38.57 billion$34.30 billionViewN/AView Earnings Details
10/24/2013Q214$2.03$2.27$32.16 billion$33.00 billionViewListenView Earnings Details
7/25/2013Q1 2014$1.71$2.07$32.60 billion$32.20 billionViewListenView Earnings Details
5/7/2013Q4 2013$2.30$1.45$32.01 billion$30.62 billionViewListenView Earnings Details
1/31/2013Q3 2013$1.62$1.41$30.81 billion$31.19 billionViewListenView Earnings Details
10/25/2012$1.78$1.92ViewN/AView Earnings Details
7/26/2012$1.48$1.55ViewN/AView Earnings Details
4/30/2012$2.04$2.09ViewN/AView Earnings Details
1/30/2012$1.38$1.40ViewN/AView Earnings Details
10/25/2011$1.38$1.63ViewN/AView Earnings Details
7/28/2011$1.10$1.27ViewN/AView Earnings Details
5/3/2011$1.60$1.66ViewN/AView Earnings Details
1/31/2011$1.12$1.12ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

McKesson (NYSE:MCK) Earnings Estimates

2017 EPS Consensus Estimate: $12.80
2018 EPS Consensus Estimate: $11.96
2019 EPS Consensus Estimate: $12.74
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$3.36$3.40$3.38
Q2 20172$3.10$3.10$3.10
Q3 20172$2.85$3.46$3.16
Q4 20173$2.99$3.51$3.17
Q1 20182$2.85$2.88$2.87
Q2 20182$2.80$2.82$2.81
Q3 20182$2.80$2.90$2.85
Q4 20182$3.08$3.78$3.43
Q1 20191$2.70$2.70$2.70
Q2 20191$3.01$3.01$3.01
Q3 20191$3.22$3.22$3.22
Q4 20191$3.81$3.81$3.81
(Data provided by Zacks Investment Research)

Dividends

McKesson (NYSE:MCK) Dividend Information

Next Dividend:1/2/2018
Annual Dividend:$1.36
Dividend Yield:0.84%
Dividend Growth:10.10% (3 Year Average)
Payout Ratio:6.45% (Trailing 12 Months of Earnings)
11.16% (Based on This Year's Estimates)
10.55% (Based on Next Year's Estimates)
Track Record:4 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for McKesson (NYSE:MCK)

McKesson (NYSE:MCK) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/26/2017quarterly$0.341%11/30/201712/1/20171/2/2018
7/26/2017quarterly$0.340.84%8/30/20179/1/201710/2/2017
5/24/2017quarterly$0.280.69%6/1/20176/5/20177/3/2017
1/25/2017quarterly$0.280.81%2/27/20173/1/20174/3/2017
10/27/2016quarterly$0.280.9%11/29/201612/1/20161/2/2017
7/26/2016quarterly$0.280.57%8/30/20169/1/201610/3/2016
5/25/2016quarterly$0.280.62%6/2/20166/6/20167/1/2016
1/27/2016quarterly$0.280.7%2/26/20163/1/20164/1/2016
10/30/2015quarterly$0.280.62%11/27/201512/1/20151/4/2016
7/29/2015quarterly$0.280.52%8/28/20159/1/201510/1/2015
5/27/2015quarterly$0.240.4%6/4/20156/8/20157/1/2015
1/29/2015quarterly$0.240.44%2/26/20153/2/20154/1/2015
10/21/2014quarterly$0.240.49%11/26/201412/1/20141/2/2015
7/30/2014quarterly$0.240.49%8/28/20149/2/201410/1/2014
5/28/2014quarterly$0.240.51%6/5/20146/9/20147/1/2014
1/29/2014quarterly$0.240.54%2/27/20143/3/20144/1/2014
10/25/2013quarterly$0.240.63%11/27/201312/2/20131/2/2014
7/25/2013quarterly$0.240.77%8/29/20139/3/201310/1/2013
5/22/2013quarterly$0.220.68%6/5/20136/7/20137/1/2013
1/30/2013quarterly$0.200.76%2/27/20133/1/20134/1/2013
(Data available from 1/1/2013 forward)

Insider Trades

McKesson (NYSE MCK) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.20%
Institutional Ownership Percentage: 88.10%
Insider Trades by Quarter for McKesson (NYSE:MCK)
Institutional Ownership by Quarter for McKesson (NYSE:MCK)

McKesson (NYSE MCK) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/29/2017John H HammergrenCEOSell99,000$153.89$15,235,110.00View SEC Filing  
9/28/2017John H HammergrenCEOSell100,000$153.51$15,351,000.00View SEC Filing  
9/27/2017John H HammergrenCEOSell100,000$155.30$15,530,000.00View SEC Filing  
9/26/2017John H HammergrenCEOSell100,000$154.81$15,481,000.00View SEC Filing  
9/25/2017John H HammergrenCEOSell100,000$154.15$15,415,000.00View SEC Filing  
9/22/2017John H. HammergrenChairmanSell225,000$151.67$34,125,750.00View SEC Filing  
9/22/2017John H. HammergrenCEOSell100,000$153.53$15,353,000.00View SEC Filing  
9/20/2017John H. HammergrenCEOSell125,000$150.18$18,772,500.00View SEC Filing  
9/7/2017Erin M. LampertSVPSell900$155.65$140,085.00View SEC Filing  
8/21/2017M Christine JacobsDirectorSell1,083$145.43$157,500.69View SEC Filing  
7/31/2017Marie L/Ca KnowlesDirectorSell1,083$162.55$176,041.65View SEC Filing  
6/1/2017John H HammergrenChairmanSell38,619$163.76$6,324,247.44View SEC Filing  
5/31/2017Erin M LampertSVPSell809$160.66$129,973.94View SEC Filing  
5/30/2017Erin M LampertSVPSell404$160.53$64,854.12View SEC Filing  
5/30/2017John H HammergrenChairmanSell19,316$162.31$3,135,179.96View SEC Filing  
3/29/2017John H HammergrenChairmanSell100,500$150.44$15,119,220.00View SEC Filing  
3/2/2017John H HammergrenChairmanSell100,500$150.49$15,124,245.00View SEC Filing  
12/5/2016Wayne A. BuddDirectorSell723$145.77$105,391.71View SEC Filing  
11/30/2016Lori A SchechterEVPBuy692$144.52$100,007.84View SEC Filing  
11/2/2016Susan R SalkaDirectorBuy1,000$136.35$136,350.00View SEC Filing  
10/31/2016Erin M LampertSVPSell921$123.99$114,194.79View SEC Filing  
10/3/2016Erin M. LampertSVPSell1,739$165.94$288,569.66View SEC Filing  
9/12/2016John H HammergrenChairmanSell100,500$180.77$18,167,385.00View SEC Filing  
9/12/2016Wayne A BuddDirectorSell2,309$179.70$414,927.30View SEC Filing  
9/6/2016John H HammergrenChairmanSell100,500$184.22$18,514,110.00View SEC Filing  
8/22/2016M Christine JacobsDirectorSell915$193.78$177,308.70View SEC Filing  
8/1/2016Marie L/Ca KnowlesDirectorSell915$192.73$176,347.95View SEC Filing  
7/14/2016James A BeerCFOSell5,500$199.00$1,094,500.00View SEC Filing  
5/25/2016John H HammergrenCEOSell37,420$182.87$6,842,995.40View SEC Filing  
5/25/2016Patrick BlakeEVPSell6,322$182.87$1,156,104.14View SEC Filing  
5/24/2016John H HammergrenCEOSell18,709$182.06$3,406,160.54View SEC Filing  
5/24/2016Lori A SchechterEVPSell107$182.06$19,480.42View SEC Filing  
5/23/2016John H HammergrenCEOSell18,718$179.33$3,356,698.94View SEC Filing  
5/23/2016Patrick BlakeEVPSell3,162$179.33$567,041.46View SEC Filing  
5/10/2016John H HammergrenCEOSell101,833$170.71$17,383,911.43View SEC Filing  
4/25/2016John H HammergrenCEOSell101,833$176.81$18,005,092.73View SEC Filing  
4/4/2016John H HammergrenCEOSell45,300$159.00$7,202,700.00View SEC Filing  
3/15/2016Nigel A ReesSVPSell6,000$157.59$945,540.00View SEC Filing  
2/2/2016Susan R SalkaDirectorBuy1,000$156.21$156,210.00View SEC Filing  
2/1/2016Lori A. SchechterEVPSell2,476$159.73$395,491.48View SEC Filing  
1/4/2016John H. HammergrenCEOSell101,833$194.11$19,766,803.63View SEC Filing  
12/1/2015John H. HammergrenCEOSell101,833$190.06$19,354,379.98View SEC Filing  
11/24/2015John H. HammergrenCEOSell56,533$190.01$10,741,835.33View SEC Filing  
10/12/2015John H. HammergrenCEOSell101,835$190.51$19,400,585.85View SEC Filing  
8/13/2015Paul C JulianEVPSell55,666$214.54$11,942,583.64View SEC Filing  
7/15/2015Paul C JulianEVPSell27,833$234.04$6,514,035.32View SEC Filing  
7/14/2015Paul C JulianEVPSell27,833$232.86$6,481,192.38View SEC Filing  
6/17/2015Paul C JulianEVPSell55,668$234.06$13,029,652.08View SEC Filing  
5/28/2015John H HammergrenCEOSell60,000$238.53$14,311,800.00View SEC Filing  
5/28/2015Lori A SchechterEVPSell1,468$238.22$349,706.96View SEC Filing  
5/26/2015John H HammergrenCEOSell30,062$238.97$7,183,916.14View SEC Filing  
5/26/2015Paul C JulianEVPSell15,289$238.97$3,653,612.33View SEC Filing  
5/22/2015Jorge FigueredoEVPSell20,775$240.11$4,988,285.25View SEC Filing  
5/15/2015Jorge FigueredoEVPSell8,525$240.00$2,046,000.00View SEC Filing  
2/17/2015Randall N SprattEVPSell44,523$225.00$10,017,675.00View SEC Filing  
2/12/2015Randall N SprattEVPSell7,477$225.00$1,682,325.00View SEC Filing  
2/10/2015Alton F Irby IIIDirectorSell5,000$220.76$1,103,800.00View SEC Filing  
2/10/2015Nigel A ReesMajor ShareholderSell9,000$220.42$1,983,780.00View SEC Filing  
1/28/2015John H HammergrenCEOSell64,521$219.52$14,163,649.92View SEC Filing  
1/26/2015Brian Scott TylerEVPSell5,431$216.62$1,176,463.22View SEC Filing  
1/26/2015John H HammergrenCEOSell35,479$219.07$7,772,384.53View SEC Filing  
1/7/2015John H HammergrenCEOSell77,100$214.00$16,499,400.00View SEC Filing  
12/8/2014John H HammergrenCEOSell12,200$214.01$2,610,922.00View SEC Filing  
11/28/2014Patrick BlakeEVPSell19,000$210.00$3,990,000.00View SEC Filing  
11/24/2014John H HammergrenCEOSell100,000$209.25$20,925,000.00View SEC Filing  
11/12/2014Paul C JulianEVPSell74,666$202.51$15,120,611.66View SEC Filing  
10/31/2014Patrick BlakeEVPSell38,000$204.68$7,777,840.00View SEC Filing  
10/8/2014Paul C JulianEVPSell74,667$195.86$14,624,278.62View SEC Filing  
10/7/2014John H HammergrenCEOSell100,000$197.28$19,728,000.00View SEC Filing  
9/10/2014Paul C JulianEVPSell74,667$196.76$14,691,478.92View SEC Filing  
8/29/2014Jorge FigueredoEVPSell24,500$195.00$4,777,500.00View SEC Filing  
8/8/2014M Christine JacobsDirectorSell2,619$189.88$497,295.72View SEC Filing  
8/5/2014Marie L/Ca KnowlesDirectorSell785$192.10$150,798.50View SEC Filing  
6/2/2014Patrick BlakeEVPSell15,000$190.00$2,850,000.00View SEC Filing  
5/29/2014Paul C JulianEVPSell21,057$186.89$3,935,342.73View SEC Filing  
5/28/2014Alton F Irby IIIDirectorSell4,000$182.73$730,920.00View SEC Filing  
5/28/2014John H HammergrenCEOSell125,596$183.31$23,023,002.76View SEC Filing  
5/28/2014Jorge FigueredoEVPSell20,542$183.30$3,765,348.60View SEC Filing  
5/27/2014Brian Scott TylerEVPSell3,916$183.30$717,802.80View SEC Filing  
5/22/2014Brian Scott TylerEVPSell8,250$184.17$1,519,402.50View SEC Filing  
3/21/2014Jorge FigueredoEVPSell23,684$185.81$4,400,724.04View SEC Filing  
3/10/2014Patrick BlakeEVPSell38,750$180.36$6,988,950.00View SEC Filing  
2/4/2014Brian Scott TylerEVPSell6,250$169.68$1,060,500.00View SEC Filing  
1/22/2014Alton Irby IIIDirectorSell1,300$167.98$218,374.00View SEC Filing  
11/1/2013Nigel A ReesCFOSell7,000$158.72$1,111,040.00View SEC Filing  
10/29/2013Brian Scott TylerEVPSell8,250$153.44$1,265,880.00View SEC Filing  
10/11/2013Brian Scott TylerEVPSell9,000$138.51$1,246,590.00View SEC Filing  
10/9/2013Paul JulianEVPSell84,000$134.04$11,259,360.00View SEC Filing  
10/8/2013Brian Scott TylerEVPSell9,000$138.00$1,242,000.00View SEC Filing  
9/11/2013Paul C JulianEVPSell84,000$126.20$10,600,800.00View SEC Filing  
8/7/2013Paul JulianEVPSell84,000$123.29$10,356,360.00View SEC Filing  
8/6/2013Marie L/Ca KnowlesDirectorSell1,223$123.54$151,089.42View SEC Filing  
7/30/2013Brian Scott TylerEVPSell6,250$123.94$774,625.00View SEC Filing  
6/19/2013Paul C JulianEVPSell84,750$114.89$9,736,927.50View SEC Filing  
6/14/2013David M LawrenceDirectorSell7,500$114.28$857,100.00View SEC Filing  
6/14/2013Jorge FigueredoEVPSell6,250$115.00$718,750.00View SEC Filing  
6/10/2013Jorge FigueredoEVPSell10,000$115.00$1,150,000.00View SEC Filing  
6/4/2013Jorge FigueredoEVPSell22,500$113.63$2,556,675.00View SEC Filing  
5/30/2013Laureen SeegerEVPSell57,750$114.89$6,634,897.50View SEC Filing  
5/29/2013John H HammergrenCEOSell230,484$115.21$26,554,061.64View SEC Filing  
5/29/2013Randall N SprattEVPSell32,226$115.21$3,712,757.46View SEC Filing  
5/28/2013Brian Scott TylerEVPSell6,023$116.33$700,655.59View SEC Filing  
5/28/2013Jeffrey C CampbellCFOSell73,102$116.33$8,503,955.66View SEC Filing  
5/24/2013Laureen SeegerEVPSell17,250$116.50$2,009,625.00View SEC Filing  
5/22/2013Laureen SeegerEVPSell17,250$118.13$2,037,742.50View SEC Filing  
5/20/2013Brian Scott TylerEVPSell5,000$117.81$589,050.00View SEC Filing  
5/15/2013Nigel A ReesVPSell8,000$116.00$928,000.00View SEC Filing  
5/10/2013Brian Scott TylerEVPSell6,250$115.59$722,437.50View SEC Filing  
5/10/2013John H HammergrenCEOSell75,000$115.30$8,647,500.00View SEC Filing  
1/18/2013Jorge FigueredoEVPSell2,500$103.22$258,050.00View SEC Filing  
1/17/2013Laureen SeegerEVPSell17,250$103.00$1,776,750.00View SEC Filing  
9/4/2012Paul C JulianEVPSell36,250$87.02$3,154,475.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

McKesson (NYSE MCK) News Headlines

Source:
DateHeadline
How Did McKesson Corporation’s (NYSE:MCK) 39.56% ROE Fare Against The Industry?How Did McKesson Corporation’s (NYSE:MCK) 39.56% ROE Fare Against The Industry?
finance.yahoo.com - December 17 at 9:57 AM
Kirsten Gillibrand, Long a Champion of Women, Finds the Nation Joining HerKirsten Gillibrand, Long a Champion of Women, Finds the Nation Joining Her
www.nytimes.com - December 16 at 4:51 PM
Sales Growth Hurt McKesson (MCK) RatingSales Growth Hurt McKesson (MCK) Rating
investorplace.com - December 13 at 3:12 PM
Zacks: Analysts Anticipate McKesson Co. (MCK) Will Announce Quarterly Sales of $52.00 BillionZacks: Analysts Anticipate McKesson Co. (MCK) Will Announce Quarterly Sales of $52.00 Billion
www.americanbankingnews.com - December 12 at 4:16 AM
Secret McKesson Records Show Failed Opioid Oversight, Suit SaysSecret McKesson Records Show Failed Opioid Oversight, Suit Says
finance.yahoo.com - December 8 at 4:49 PM
Stock of McKesson (MCK) Falls to SellStock of McKesson (MCK) Falls to Sell
investorplace.com - December 6 at 3:21 PM
McKesson (MCK) Receives New Coverage from Analysts at Deutsche BankMcKesson (MCK) Receives New Coverage from Analysts at Deutsche Bank
www.americanbankingnews.com - December 4 at 11:10 PM
McKesson RxO Team Identifies Five Health System Pharmacy Trends to Watch in 2018McKesson RxO Team Identifies Five Health System Pharmacy Trends to Watch in 2018
www.businesswire.com - December 4 at 4:54 PM
McKesson Corp. : MCK-US: Dividend Analysis : December 01st, 2017 (record date) : By the numbers : December 4, 2017McKesson Corp. : MCK-US: Dividend Analysis : December 01st, 2017 (record date) : By the numbers : December 4, 2017
finance.yahoo.com - December 4 at 4:54 PM
McKesson Corporation (MCK) Given Consensus Rating of "Hold" by BrokeragesMcKesson Corporation (MCK) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - December 1 at 9:54 PM
McKesson Corporation (MCK) Ex-Dividend Date Scheduled for November 30, 2017 - NasdaqMcKesson Corporation (MCK) Ex-Dividend Date Scheduled for November 30, 2017 - Nasdaq
www.nasdaq.com - November 29 at 5:14 PM
Industry Group Rank Analytics Limit McKesson (MCK) Ratings Upgrade to HoldIndustry Group Rank Analytics Limit McKesson (MCK) Ratings Upgrade to Hold
investorplace.com - November 29 at 3:29 PM
News Corp.News Corp.
www.marketwatch.com - November 26 at 9:37 AM
$51.98 Billion in Sales Expected for McKesson Corporation (MCK) This Quarter$51.98 Billion in Sales Expected for McKesson Corporation (MCK) This Quarter
www.americanbankingnews.com - November 24 at 4:46 AM
McKesson Gains From Distribution Business Amid Pricing Woes - NasdaqMcKesson Gains From Distribution Business Amid Pricing Woes - Nasdaq
www.nasdaq.com - November 23 at 6:23 AM
McKesson Corporation (MCK) Expected to Post Earnings of $2.95 Per ShareMcKesson Corporation (MCK) Expected to Post Earnings of $2.95 Per Share
www.americanbankingnews.com - November 22 at 7:10 PM
Earnings Visibility Metrics Restrict McKesson (MCK) Ratings Upgrade to HoldEarnings Visibility Metrics Restrict McKesson (MCK) Ratings Upgrade to Hold
investorplace.com - November 22 at 3:31 PM
Chairman Maynard hands over reins at Investors Management Corp.Chairman Maynard hands over reins at Investors Management Corp.
www.bizjournals.com - November 18 at 1:30 AM
Deleterious Quant Score Drop McKesson (MCK) to SellDeleterious Quant Score Drop McKesson (MCK) to Sell
investorplace.com - November 15 at 3:52 PM
ETFs with exposure to McKesson Corp. : November 13, 2017ETFs with exposure to McKesson Corp. : November 13, 2017
finance.yahoo.com - November 13 at 3:35 PM
McKesson Corporation (MCK) Rating Reiterated by Credit Suisse GroupMcKesson Corporation (MCK) Rating Reiterated by Credit Suisse Group
www.americanbankingnews.com - November 9 at 9:34 AM
McKesson (MCK) to Acquire RxCrossroads for $735MMcKesson (MCK) to Acquire RxCrossroads for $735M
www.streetinsider.com - November 8 at 5:20 PM
UPDATE 1-Drug distributor McKesson to buy CVSs specialty distribution unitUPDATE 1-Drug distributor McKesson to buy CVS's specialty distribution unit
www.businessinsider.com - November 8 at 5:20 PM
McKesson To Buy RxCrossroadsMcKesson To Buy RxCrossroads
www.rttnews.com - November 8 at 5:20 PM
BRIEF-Mckesson acquires RxCrossroads in a deal valued at $735 mlnBRIEF-Mckesson acquires RxCrossroads in a deal valued at $735 mln
www.reuters.com - November 8 at 5:20 PM
McKesson Strengthens Its Portfolio of Manufacturer Solutions with the Acquisition of RxCrossroadsMcKesson Strengthens Its Portfolio of Manufacturer Solutions with the Acquisition of RxCrossroads
finance.yahoo.com - November 8 at 5:20 PM
Earnings Visibility Keep McKesson (MCK) a SellEarnings Visibility Keep McKesson (MCK) a Sell
investorplace.com - November 8 at 4:58 PM
McKesson Strengthens Its Portfolio of Manufacturer Solutions with ... - Business Wire (press release)McKesson Strengthens Its Portfolio of Manufacturer Solutions with ... - Business Wire (press release)
www.businesswire.com - November 7 at 6:41 AM
McKesson buys RXCrossroads from CVS for $735MMcKesson buys RXCrossroads from CVS for $735M
seekingalpha.com - November 6 at 6:55 PM
McKesson Corporation (MCK) Receives Average Recommendation of "Hold" from AnalystsMcKesson Corporation (MCK) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - November 6 at 5:48 PM
Chuck Norris sues med-tech companies, including one in Twin CitiesChuck Norris sues med-tech companies, including one in Twin Cities
finance.yahoo.com - November 3 at 4:47 PM
ETFs with exposure to McKesson Corp. : November 1, 2017ETFs with exposure to McKesson Corp. : November 1, 2017
finance.yahoo.com - November 2 at 6:16 AM
Industry Group Rank Metrics Keep McKesson (MCK) Upgrade to HoldIndustry Group Rank Metrics Keep McKesson (MCK) Upgrade to Hold
investorplace.com - November 1 at 3:55 PM
McKesson Corp. :MCK-US: Earnings Analysis: Q2, 2018 By the Numbers : October 30, 2017McKesson Corp. :MCK-US: Earnings Analysis: Q2, 2018 By the Numbers : October 30, 2017
finance.yahoo.com - November 1 at 6:09 AM
McKesson Corp. :MCK-US: Earnings Analysis: Q2, 2018 By the Numbers : October 30, 2017McKesson Corp. :MCK-US: Earnings Analysis: Q2, 2018 By the Numbers : October 30, 2017
finance.yahoo.com - November 1 at 6:09 AM
McKesson Signs Agreement With NRG to Install Solar Arrays at ... - Business Wire (press release)McKesson Signs Agreement With NRG to Install Solar Arrays at ... - Business Wire (press release)
www.businesswire.com - October 31 at 3:37 AM
Jefferies Group Comments on McKesson Corporations FY2018 Earnings (MCK)Jefferies Group Comments on McKesson Corporation's FY2018 Earnings (MCK)
www.americanbankingnews.com - October 30 at 10:34 AM
Research Analysts Issue Forecasts for McKesson Corporations FY2018 Earnings (MCK)Research Analysts Issue Forecasts for McKesson Corporation's FY2018 Earnings (MCK)
www.americanbankingnews.com - October 30 at 10:34 AM
McKesson Corporation (MCK) Rating Reiterated by Royal Bank Of CanadaMcKesson Corporation (MCK) Rating Reiterated by Royal Bank Of Canada
www.americanbankingnews.com - October 28 at 9:06 AM
Earnings Reaction History: McKesson Corporation, 55.6% Follow-Through Indicator, 5.2% Sensitive - NasdaqEarnings Reaction History: McKesson Corporation, 55.6% Follow-Through Indicator, 5.2% Sensitive - Nasdaq
www.nasdaq.com - October 28 at 8:00 AM
US stocks are mixed as tech soars, retail and energy sinkUS stocks are mixed as tech soars, retail and energy sink
marketbeat.com - October 27 at 10:52 AM
McKesson Reports Fiscal 2018 Second-Quarter ResultsMcKesson Reports Fiscal 2018 Second-Quarter Results
www.businesswire.com - October 27 at 6:37 AM
Should You Buy McKesson Corporation (MCK) Ahead of Earnings?Should You Buy McKesson Corporation (MCK) Ahead of Earnings?
www.msn.com - October 27 at 6:37 AM
McKesson (MCK) Q2 2018 Results - Earnings Call TranscriptMcKesson (MCK) Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - October 27 at 6:37 AM
McKesson beats Street 2Q forecastsMcKesson beats Street 2Q forecasts
finance.yahoo.com - October 27 at 6:37 AM
Drug distributor McKessons quarterly profit beats estimatesDrug distributor McKesson's quarterly profit beats estimates
finance.yahoo.com - October 27 at 6:37 AM
McKesson shares rise on Q2 profit, revenue beatsMcKesson shares rise on Q2 profit, revenue beats
finance.yahoo.com - October 27 at 6:37 AM
McKesson (MCK) Beats on Earnings and Sales in Q2McKesson (MCK) Beats on Earnings and Sales in Q2
finance.yahoo.com - October 27 at 6:37 AM
Lawsuits Wont Fix Opioid Epidemic, Top Drug Distributor SaysLawsuits Won't Fix Opioid Epidemic, Top Drug Distributor Says
finance.yahoo.com - October 27 at 6:37 AM
McKesson Fights Back With Strong Earnings, Revenue GainsMcKesson Fights Back With Strong Earnings, Revenue Gains
finance.yahoo.com - October 27 at 6:37 AM

SEC Filings

McKesson (NYSE:MCK) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

McKesson (NYSE:MCK) Income Statement, Balance Sheet and Cash Flow Statement

Chart

McKesson (NYSE MCK) Stock Chart for Sunday, December, 17, 2017

Loading chart…

This page was last updated on 12/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.